

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">

<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Reprod Infert</journal-id>
      <journal-id journal-id-type="publisher-id">arij001</journal-id>
      <journal-title-group>
        <journal-title>Journal of Reproduction &amp; Infertility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2228-5482</issn>
      <issn pub-type="epub">2251-676X</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">jri60055</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>The Contingent Prenatal Screening Test for Down’s Syndrome and Neural Tube Defects in West of Iran</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Aghaz</surname><given-names>Faranak</given-names></name></contrib><aff>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ojagh</surname><given-names>Seyyedeh Zeinab</given-names></name></contrib><aff>Imamreza Clinic, Kermanshah, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Khanjari</surname><given-names>Saber</given-names></name></contrib><aff> Gene targeting Lab, John Curtin School of Medical Research, The Australian National University, Kermanshah, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Vaisi-Raygani</surname><given-names>Asad</given-names></name></contrib><aff>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Khazaei</surname><given-names>Mozaffar</given-names></name></contrib><aff>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Bakhtiari</surname><given-names>Mitra</given-names></name></contrib><aff>Fertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>20</volume>
      <issue>4</issue>
      <fpage>244</fpage>
      <lpage>252</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>3</month>
          <year>2019</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>6</month>
          <year>2019</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: The purpose of the study was to evaluate the use of contingent prenatal screening for the detection of Down&amp;rsquo;s syndrome and neural tube defects (NTDs) in west of Iran.&lt;br /&gt;
Methods: A prospective study was conducted on 653 pregnant women referred to a medical diagnostic laboratory (Imam Reza Clinic, Kermanshah, Iran) for contingent prenatal screening tests between October 2016 to September 2017.&amp;nbsp;&lt;br /&gt;
Results: Among 651 women screened in the first trimester, 8 (1.22%) pregnancies were screen-positive for Down&amp;rsquo;s syndrome. In the second trimester, among 605 women, 25 (4.13%) had a positive result and all of these women voluntarily underwent amniocentesis. Overall, five pregnancies were complicated with chromosomal abnormalities, including five cases of Down&amp;rsquo;s syndrome.&amp;nbsp;&lt;br /&gt;
Conclusion: In a nutshell, the contingent prenatal screening tests were found to be useful for estimation of Down&amp;rsquo;s syndrome as well as NTDs in both young and older mothers in west of Iran. These tests should be performed for pregnant women before an invasive test for Down&amp;rsquo;s syndrome.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>

    
</article>

